부산대학교 도서관

Cormedi, Marina Candido Visontai; Van Allen, Eliezer M; Colli, Leandro Machado

In Current Opinion in Genetics & Development February 2021 66:1-9

Caswell, Deborah R; Gui, Philippe; Mayekar, Manasi K; Law, Emily K; Pich, Oriol; Bailey, Chris; Boumelha, Jesse; Kerr, D Lucas; Blakely, Collin M; Manabe, Tadashi; Martinez-Ruiz, Carlos; Bakker, Bjorn; De Dios Palomino Villcas, Juan; I. Vokes, Natalie; Dietzen, Michelle; Angelova, Mihaela; Gini, Beatrice; Tamaki, Whitney; Allegakoen, Paul; Wu, Wei; Humpton, Timothy J; Hill, William; Tomaschko, Mona; Lu, Wei-Ting; Haderk, Franziska; Al Bakir, Maise; Nagano, Ai; Gimeno-Valiente, Francisco; de Carné Trécesson, Sophie; Vendramin, Roberto; Barbè, Vittorio; Mugabo, Miriam; Weeden, Clare E; Rowan, Andrew; McCoach, Caroline E; Almeida, Bruna; Green, Mary; Gomez, Carlos; Nanjo, Shigeki; Barbosa, Dora; Moore, Chris; Przewrocka, Joanna; Black, James RM; Grönroos, Eva; Suarez-Bonnet, Alejandro; Priestnall, Simon L; Zverev, Caroline; Lighterness, Scott; Cormack, James; Olivas, Victor; Cech, Lauren; Andrews, Trisha; Rule, Brandon; Jiao, Yuwei; Zhang, Xinzhu; Ashford, Paul; Durfee, Cameron; Venkatesan, Subramanian; Temiz, Nuri Alpay; Tan, Lisa; Larson, Lindsay K; Argyris, Prokopios P; Brown, William L; Yu, Elizabeth A; Rotow, Julia K; Guha, Udayan; Roper, Nitin; Yu, Johnny; Vogel, Rachel I; Thomas, Nicholas J; Marra, Antonio; Selenica, Pier; Yu, Helena; Bakhoum, Samuel F; Chew, Su Kit; Reis-Filho, Jorge S; Jamal-Hanjani, Mariam; Vousden, Karen H; McGranahan, Nicholas; Van Allen, Eliezer M; Kanu, Nnennaya; Harris, Reuben S; Downward, Julian; Bivona, Trever G; Swanton, Charles

Nature Genetics. 56(1)

Miao, Diana; Van Allen, Eliezer M

In Current Opinion in Immunology August 2016 41:32-38

Rusert, Jessica M; Juarez, Edwin F; Brabetz, Sebastian; Jensen, James; Garancher, Alexandra; Chau, Lianne Q; Tacheva-Grigorova, Silvia K; Wahab, Sameerah; Udaka, Yoko T; Finlay, Darren; Seker-Cin, Huriye; Reardon, Brendan; Gröbner, Susanne; Serrano, Jonathan; Ecker, Jonas; Qi, Lin; Kogiso, Mari; Du, Yuchen; Baxter, Patricia A; Henderson, Jacob J; Berens, Michael E; Vuori, Kristiina; Milde, Till; Cho, Yoon-Jae; Li, Xiao-Nan; Olson, James M; Reyes, Iris; Snuderl, Matija; Wong, Terence C; Dimmock, David P; Nahas, Shareef A; Malicki, Denise; Crawford, John R; Levy, Michael L; Van Allen, Eliezer M; Pfister, Stefan M; Tamayo, Pablo; Kool, Marcel; Mesirov, Jill P; Wechsler-Reya, Robert J

Cancer Research. 80(23)

Bailey, Matthew H; Tokheim, Collin; Porta-Pardo, Eduard; Sengupta, Sohini; Bertrand, Denis; Weerasinghe, Amila; Colaprico, Antonio; Wendl, Michael C; Kim, Jaegil; Reardon, Brendan; Ng, Patrick Kwok-Shing; Jeong, Kang Jin; Cao, Song; Wang, Zixing; Gao, Jianjiong; Gao, Qingsong; Wang, Fang; Liu, Eric Minwei; Mularoni, Loris; Rubio-Perez, Carlota; Nagarajan, Niranjan; Cortés-Ciriano, Isidro; Zhou, Daniel Cui; Liang, Wen-Wei; Hess, Julian M; Yellapantula, Venkata D; Tamborero, David; Gonzalez-Perez, Abel; Suphavilai, Chayaporn; Ko, Jia Yu; Khurana, Ekta; Park, Peter J; Van Allen, Eliezer M; Liang, Han; Lawrence, Michael S; Godzik, Adam; Lopez-Bigas, Nuria; Stuart, Joshua M; Wheeler, David A; Getz, Gad; Chen, Amy; Lazar, Alexander J; Mills, Gordon B; Karchin, Rachel; Ding, Li; Caesar-Johnson, Samantha J; Demchok, John A; Felau, Ina; Kasapi, Melpomeni; Ferguson, Martin L; Hutter, Carolyn M; Sofia, Heidi J; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean C; Zhang, Jiashan; Chudamani, Sudha; Liu, Jia; Lolla, Laxmi; Naresh, Rashi; Pihl, Todd; Sun, Qiang; Wan, Yunhu; Wu, Ye; Cho, Juok; DeFreitas, Timothy; Frazer, Scott; Gehlenborg, Nils; Heiman, David I; Lin, Pei; Meier, Sam; Noble, Michael S; Saksena, Gordon; Voet, Doug; Zhang, Hailei; Bernard, Brady; Chambwe, Nyasha; Dhankani, Varsha; Knijnenburg, Theo; Kramer, Roger; Leinonen, Kalle; Liu, Yuexin; Miller, Michael; Reynolds, Sheila; Shmulevich, Ilya; Thorsson, Vesteinn; Zhang, Wei; Akbani, Rehan; Broom, Bradley M; Hegde, Apurva M; Ju, Zhenlin; Kanchi, Rupa S; Korkut, Anil; Li, Jun; Ling, Shiyun

Cell. 174(4)

Yates J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Institute for Machine Learning, Department of Computer Science, ETH Zürich, Zurich, Switzerland; ETH AI Center, ETH Zurich, Zurich, Switzerland; Swiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Division of Medical Sciences, Harvard University, Boston, MA, USA; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: eliezerm_vanallen@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Jiang Q; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Braun DA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, CT 06511, USA.; Clauser KR; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Ramesh V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Shirole NH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Duke-Cohan JE; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Nabilsi N; TScan Therapeutics, Waltham, MA 02451, USA.; Kramer NJ; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Lippincott IE; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Klaeger S; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Phulphagar KM; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Chea V; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Kim N; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Vanasse AP; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Saad E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Parsons T; TScan Therapeutics, Waltham, MA 02451, USA.; Carr-Reynolds M; TScan Therapeutics, Waltham, MA 02451, USA.; Carulli I; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Pinjusic K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Jiang Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Syamala S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Rachimi S; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Verzani EK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Stevens JD; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Lane WJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA.; Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Meli K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Pappalardi MB; Cancer Epigenetics Research Unit, Oncology, GSK, Collegeville, PA 19426, USA.; Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Shukla SA; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA.; Churchman LS; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.; Abelin JG; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.; Gurer C; TScan Therapeutics, Waltham, MA 02451, USA.; MacBeath G; TScan Therapeutics, Waltham, MA 02451, USA.; Childs RW; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. Electronic address: scarr@broad.mit.edu.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Computer Science, Metropolitan College, Boston University, Boston, MA 02215, USA; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark 2800 Lyngby, Denmark. Electronic address: derin_keskin@dfci.harvard.edu.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA. Electronic address: catherine_wu@dfci.harvard.edu.; Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: william_kaelin@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Huang, Franklin W; Mosquera, Juan Miguel; Garofalo, Andrea; Oh, Coyin; Baco, Maria; Amin-Mansour, Ali; Rabasha, Bokang; Bahl, Samira; Mullane, Stephanie A; Robinson, Brian D; Aldubayan, Saud; Khani, Francesca; Karir, Beerinder; Kim, Eejung; Chimene-Weiss, Jeremy; Hofree, Matan; Romanel, Alessandro; Osborne, Joseph R; Kim, Jong Wook; Azabdaftari, Gissou; Woloszynska-Read, Anna; Sfanos, Karen; De Marzo, Angelo M; Demichelis, Francesca; Gabriel, Stacey; Van Allen, Eliezer M; Mesirov, Jill; Tamayo, Pablo; Rubin, Mark A; Powell, Isaac J; Garraway, Levi A

Cancer Discovery. 7(9)

Kim, Jong Wook; Abudayyeh, Omar O; Yeerna, Huwate; Yeang, Chen-Hsiang; Stewart, Michelle; Jenkins, Russell W; Kitajima, Shunsuke; Konieczkowski, David J; Medetgul-Ernar, Kate; Cavazos, Taylor; Mah, Clarence; Ting, Stephanie; Van Allen, Eliezer M; Cohen, Ofir; Mcdermott, John; Damato, Emily; Aguirre, Andrew J; Liang, Jonathan; Liberzon, Arthur; Alexe, Gabriella; Doench, John; Ghandi, Mahmoud; Vazquez, Francisca; Weir, Barbara A; Tsherniak, Aviad; Subramanian, Aravind; Meneses-Cime, Karina; Park, Jason; Clemons, Paul; Garraway, Levi A; Thomas, David; Boehm, Jesse S; Barbie, David A; Hahn, William C; Mesirov, Jill P; Tamayo, Pablo

Cell Systems. 5(2)

Skoulidis F; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. fskoulidis@mdanderson.org.; Araujo HA; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do MT; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qian Y; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sun X; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cobo AG; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Le JT; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montesion M; Foundation Medicine, Cambridge, MA, USA.; Palmer R; Pionyr Immunotherapeutics, South San Francisco, CA, USA.; Jahchan N; Pionyr Immunotherapeutics, South San Francisco, CA, USA.; Juan JM; D2G Oncology, Mountain View, CA, USA.; Min C; Tango Therapeutics, Boston, MA, USA.; Yu Y; Tango Therapeutics, Boston, MA, USA.; Pan X; Tango Therapeutics, Boston, MA, USA.; Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Vokes N; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Schmidt ST; Department of Genomic Medicine and the Institute for Data Science in Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Molkentine D; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Owen DH; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.; Memmott R; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.; Patil PD; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Marmarelis ME; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Murray JC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Hellyer JA; Department of Genetics, Stanford University, Stanford, CA, USA.; Gainor JF; Massachussetts General Hospital, Boston, MA, USA.; Dimou A; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Bestvina CM; Department of Medicine, University of Chicago, Chicago, IL, USA.; Shu CA; Columbia University, New York, NY, USA.; Riess JW; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.; Blakely CM; University of California San Francisco, San Francisco, CA, USA.; Pecot CV; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Mezquita L; Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.; Tabbó F; Ospedale Michele e Pietro Ferrero, Cuneo, Italy.; Scheffler M; Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.; Digumarthy S; Department of Radiology, Massachussetts General Hospital, Boston, MA, USA.; Mooradian MJ; Massachussetts General Hospital, Boston, MA, USA.; Sacher AG; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Lau SCM; Department of Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA.; Saltos AN; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Rotow J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Johnson RP; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Liu C; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Stewart T; Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.; Goldberg SB; Yale School of Medicine, New Haven, CT, USA.; Killam J; North Shore University Hospital, Manhasset, NY, USA.; Walther Z; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Schalper K; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.; Davies KD; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Woodcock MG; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Marrone KA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Forde PM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Van Allen EM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cummings AL; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.; Goldman JW; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.; Shaish H; Columbia University, New York, NY, USA.; Kier M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Katz S; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Aggarwal C; Division of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Ni Y; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Azok JT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Segal J; Department of Pathology, University of Chicago, Chicago, USA.; Ritterhouse L; Foundation Medicine, Cambridge, MA, USA.; Neal JW; Department of Genetics, Stanford University, Stanford, CA, USA.; Lacroix L; Institut Gustave Roussy, Villejuif, France.; Elamin YY; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Negrao MV; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Le X; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lam VK; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Lewis WE; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kemp HN; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carter B; Department of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Roth JA; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Swisher S; Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee R; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhou T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Poteete A; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kong Y; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takehara T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Paula AG; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Parra Cuentas ER; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Behrens C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wistuba II; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Blumenschein GR; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay C; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Byers LA; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gibbons DL; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tsao A; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee JJ; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bivona TG; University of California San Francisco, San Francisco, CA, USA.; Camidge DR; University of Colorado Cancer Center, Denver, CO, USA.; Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Leighl NB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Levy B; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Brahmer JR; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Garassino MC; Department of Medicine, University of Chicago, Chicago, IL, USA.; Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.; Garon EB; David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.; Rizvi NA; Synthekine, Menlo Park, CA, USA.; Scagliotti GV; University of Turin, Orbassano, Italy.; Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.; Planchard D; Institut Gustave Roussy, Villejuif, France.; Besse B; Institut Gustave Roussy, Villejuif, France.; Herbst RS; Yale School of Medicine, New Haven, CT, USA.; Wakelee HA; Department of Genetics, Stanford University, Stanford, CA, USA.; Pennell NA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Shaw AT; Novartis Institute for Biomedical Research, Cambridge, MA, USA.; Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Carbone DP; Division of Medical Oncology, Ohio State University-James Comprehensive Cancer Center, Columbus, OH, USA.; Hellmann MD; AstraZeneca, Gaithersburg, MD, USA.; Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Albacker L; Foundation Medicine, Cambridge, MA, USA.; Mann H; AstraZeneca, Cambridge, UK.; Zhu Z; AstraZeneca, Cambridge, UK.; Lai Z; AstraZeneca, Cambridge, UK.; Stewart R; AstraZeneca, Cambridge, UK.; Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland.; Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA.; Wong KK; Division of Hematology & Medical Oncology, NYU Langone Perlmutter Cancer Center, New York, NY, USA.; Huang A; Tango Therapeutics, Boston, MA, USA.; Winslow MM; D2G Oncology, Mountain View, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA.; Rosen MJ; D2G Oncology, Mountain View, CA, USA.; Winters IP; D2G Oncology, Mountain View, CA, USA.; Papadimitrakopoulou VA; Pfizer, New York, NY, USA.; Cascone T; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jewsbury P; AstraZeneca, Cambridge, UK.; Heymach JV; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jheymach@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: PubMed not MEDLINE; MEDLINE

Johri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Titchen BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Graduate Program in Biological and Biomedical Sciences, Boston, MA, USA.; Fu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Conway J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Graduate Program in Bioinformatics and Integrative Genomics, Boston, MA, USA.; Crowdis JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Vokes NI; Department of Thoracic and Head and Neck Oncology, MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.; Fan Z; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA.; Fong L; Division of Hematology/Oncology, University of California, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA, USA.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. eliezerm_vanallen@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. eliezerm_vanallen@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Pimenta EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; David Liposarcoma Research Initiative, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Garza AE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Hoffman SE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Boston, MA 02115, USA.; Harvard-MIT MD-PhD Program, Harvard Medical School, Boston, MA, 02115, USA.; Valderrábano L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Fu J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, 02115, USA.; Bi K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Karam J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Titchen BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Boston, MA 02115, USA.; Khandekar MJ; David Liposarcoma Research Initiative, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Shannon E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Kang YJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Nag A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Thorner AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Raut CP; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Hornick JL; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Merriam P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Solimini NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; David Liposarcoma Research Initiative, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Ludwig Center at Harvard, Boston, MA, 02115, USA.; George S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Demetri GD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; David Liposarcoma Research Initiative, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Ludwig Center at Harvard, Boston, MA, 02115, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; David Liposarcoma Research Initiative, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Collins RL; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Crowdis J; Harvard Medical School, Boston, MA, USA.; Garza A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jones JK; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Harvard/MIT MD-PhD Program, Harvard Medical School, Boston, MA, USA.; Walker M; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sanchis-Juan A; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Whelan CW; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Pierce-Hoffman E; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Talkowski ME; Harvard Medical School, Boston, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Brand H; Harvard Medical School, Boston, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Haigis K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; LoPiccolo J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; AlDubayan SH; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; College of Medicine, King Saudi bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Gusev A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Crompton BD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Van Allen EM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Johri S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Jeong J; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Department of Computer Science, Stanford University, Stanford, CA, USA.; Tran BA; Department of Dermatology, Medstar Georgetown University Hospital/Washington Hospital Center, Washington, DC, USA.; Schlessinger DI; Department of Dermatology, Northwestern University, Chicago, IL, USA.; Wongvibulsin S; Division of Dermatology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.; Barnes LA; Department of Dermatology, Stanford University, Stanford, CA, USA.; Zhou HY; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.; Cai ZR; Department of Dermatology, Stanford University, Stanford, CA, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kim D; Department of Emergency Medicine, Stanford University, Stanford, CA, USA.; Daneshjou R; Department of Dermatology, Stanford University, Stanford, CA, USA. roxanad@stanford.edu.; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA. roxanad@stanford.edu.; Rajpurkar P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. pranav_rajpurkar@hms.harvard.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Lyu A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Immunotherapy Integrated Research Center, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fan Z; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Clark M; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Lea A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Luong D; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Setayesh A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Starzinski A; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Wolters R; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Arias-Badia M; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Allaire K; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Wu K; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Gurunathan V; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Valderrábano L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wei XX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Miller RA; Corvus Pharmaceuticals, Burlingame, CA, USA.; Van Allen EM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Fong L; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. lawrence.fong@fredhutch.org.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. lawrence.fong@fredhutch.org.; Immunotherapy Integrated Research Center, Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA, USA. lawrence.fong@fredhutch.org.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. lawrence.fong@fredhutch.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Kim, Jong Wook; Botvinnik, Olga B; Abudayyeh, Omar; Birger, Chet; Rosenbluh, Joseph; Shrestha, Yashaswi; Abazeed, Mohamed E; Hammerman, Peter S; DiCara, Daniel; Konieczkowski, David J; Johannessen, Cory M; Liberzon, Arthur; Alizad-Rahvar, Amir Reza; Alexe, Gabriela; Aguirre, Andrew; Ghandi, Mahmoud; Greulich, Heidi; Vazquez, Francisca; Weir, Barbara A; Van Allen, Eliezer M; Tsherniak, Aviad; Shao, Diane D; Zack, Travis I; Noble, Michael; Getz, Gad; Beroukhim, Rameen; Garraway, Levi A; Ardakani, Masoud; Romualdi, Chiara; Sales, Gabriele; Barbie, David A; Boehm, Jesse S; Hahn, William C; Mesirov, Jill P; Tamayo, Pablo

Nature Biotechnology. 34(5)

Van Allen, Eliezer M; Lui, Vivian WY; Egloff, Ann Marie; Goetz, Eva M; Li, Hua; Johnson, Jonas T; Duvvuri, Umamaheswar; Bauman, Julie E; Stransky, Nicolas; Zeng, Yan; Gilbert, Breean R; Pendleton, Kelsey P; Wang, Lin; Chiosea, Simion; Sougnez, Carrie; Wagle, Nikhil; Zhang, Fan; Du, Yu; Close, David; Johnston, Paul A; McKenna, Aaron; Carter, Scott L; Golub, Todd R; Getz, Gad; Mills, Gordon B; Garraway, Levi A; Grandis, Jennifer R

JAMA Oncology. 1(2)

Yuan, Yuan; Van Allen, Eliezer M; Omberg, Larsson; Wagle, Nikhil; Amin-Mansour, Ali; Sokolov, Artem; Byers, Lauren A; Xu, Yanxun; Hess, Kenneth R; Diao, Lixia; Han, Leng; Huang, Xuelin; Lawrence, Michael S; Weinstein, John N; Stuart, Josh M; Mills, Gordon B; Garraway, Levi A; Margolin, Adam A; Getz, Gad; Liang, Han

Nature Biotechnology. 32(7)

Rosenberg, Jonathan E; Bambury, Richard M; Van Allen, Eliezer M; Drabkin, Harry A; Lara, Primo N; Harzstark, Andrea L; Wagle, Nikhil; Figlin, Robert A; Smith, Gregory W; Garraway, Levi A; Choueiri, Toni; Erlandsson, Fredrik; Laber, Damian A

Investigational New Drugs. 32(1)

Tarantino G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ricker CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wang A; Harvard Medical School, Boston, MA, USA.; Ge W; Harvard Medical School, Boston, MA, USA.; Aprati TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.; Madha S; Worcester Polytechnic Institute, Worcester, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Shi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Glettig M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Feng CH; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Frederick DT; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Freeman S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Holovatska MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Zimmer L; Department of Dermatology, University HospitalEssen, Essen, Germany.; Rösch A; Department of Dermatology, University HospitalEssen, Essen, Germany.; Zaremba A; Department of Dermatology, University HospitalEssen, Essen, Germany.; Livingstone E; Department of Dermatology, University HospitalEssen, Essen, Germany.; Jameson JC; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, USA.; Saghafian S; Harvard Kennedy School, Harvard University, Cambridge, MA, USA.; Lee A; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Zhao K; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Morris LGT; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Elmarakeby HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Al-Azhar University, Cairo, Egypt.; Schilling B; Department of Dermatology, University HospitalEssen, Essen, Germany.; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.; Giobbie-Hurder A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Flaherty KT; Massachusetts General Hospital, Boston, MA, USA.; Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Boland GM; Massachusetts General Hospital, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schadendorf D; Department of Dermatology, University HospitalEssen, Essen, Germany.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE